Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives
Hanno Sjuts(Goethe University Frankfurt), Timothy J. Opperman(Microbiotix (United States)), Terry L. Bowlin(Microbiotix (United States)), Xiaoyuan Ding(Microbiotix (United States)), Paolo Ruggerone(University of Cagliari), Steven M. Kwasny(Microbiotix (United States)), Hiroshi Nikaido(University of California, Berkeley), Klaas M. Pos(Goethe University Frankfurt), Son T. Nguyen(Microbiotix (United States)), A.R. Ornik(Goethe University Frankfurt), Hong‐Suk Kim(University of California, Berkeley), Attilio V. Vargiu(University of Cagliari)
Cited by 207
Related Papers
Multidrug efflux pumps: structure, function and regulation
|Nature Reviews Microbiology|2018|1k
Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop
|Proceedings of the National Academy of Sciences|2012|343
Mechanisms of envelope permeability and antibiotic influx and efflux in Gram-negative bacteria
|Nature Microbiology|2017|324
Drug transport mechanism of the AcrB efflux pump
|Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics|2009|302